Loading insider details...
Latest Form 4 (Sep 3, 2026): Exercise/Conversion of 10,000 AXSM shares, $129.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 10,000 | $129.5K |
| May 6, 2026 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 4,517 | $58.5K |
| Apr 24, 2026 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 8,669 | n/a |
| Feb 28, 2026 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 19,663 | n/a |
| Feb 28, 2026 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 35,378 | $100.8K |
| Sep 22, 2025 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 10,000 | $28.5K |
| Sep 17, 2025 | Axsome Therapeutics, Inc. (AXSM) | Sale | 5,783 | $671.9K |
| Jun 10, 2025 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 25,000 | $200.5K |
| May 28, 2025 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 20,673 | $133.8K |
| Feb 25, 2025 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 10,875 | n/a |